Ablation therapy represents a significant innovation in cancer care. Advanced thermocouple wires are helping to deliver ...

CorFlow Therapeutics is set to initiate a pivotal trial of its CorFlow CoFl system across US hospitals for heart attack.

Morphic Medical has obtained an EU CE mark for RESET, a device designed to target the underlying cause of obesity and type 2 diabetes (T2D).

Miach Orthopaedics has completed the enrolment for the BEAR MOON study, which compares the collagen-based BEAR Implant.

The US FDA has approved Boston Scientific’s expanded instructions for use (IFU) labelling of the Farapulse Pulsed Field Ablation (PFA) System.